NCT00141570

Study of the Efficacy of ESTRATEST® H.S. Tablets in Relieving Menopausal Symptoms in Estrogenized Postmenopausal Women

A Multi-Center, Double-Blind Study to Determine the Efficacy of ESTRATEST® H.S. Tablets in Relieving Menopausal Symptoms in Estrogenized Postmenopausal Women

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 350 (planned)
• Sponsor: Solvay Pharmaceuticals · Industry
• Sex: Female
• Age: 30 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

To determine whether treatment with ESTRATEST® H.S. Tablets is superior to treatment with esterified estrogens tablets

Conditions

• Menopause

Interventions

Type	Name	Description
DRUG	esterified estrogens 0.625 mg and methyltestosterone 1.25 mg

Timeline

• Start date: 2004-06-01
• Primary completion: 2007-06-01
• Completion: 2007-06-01
• First posted: 2005-09-01
• Last updated: 2015-01-16

Locations

77 sites across 1 country: United States